Skip to main content
Premium Trial:

Request an Annual Quote

Second Vaccine for EU

The European Union's drug regulator has given the green light to Moderna's SARS-CoV-2 vaccine, the Wall Street Journal reports. The European Commission still has to formalize the approval, the New York Times adds, noting that can take up to two days.

This is the second SARS-CoV-2 vaccine cleared by the European Medicines Agency, which recommended the Pfizer-BioNTech vaccine for approval last month. Since then, the EU has been offering the vaccine to nursing home residents and healthcare workers, according to the Journal.

This new approval "provides us with another tool to overcome the current emergency," Emer Cooke, executive director of the EMA, tells it. "It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared."

The Journal adds that the EU has ordered 160 million doses of the Moderna vaccine, which is given in a two-dose regimen.

The US granted emergency authorization for Moderna's SARS-CoV-2 vaccine last month.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.